On September 28-30, 2016, the first European Congress of Thrombosis and Haemostasis was held in The Hague (The Netherlands).
The results of the analysis of patients with FXIII deficiency enrolled in PRO-RBDD project were submitted and accepted as oral communication: “PROSPECTIVE EVALUATION OF BLEEDING INCIDENCE IN FACTOR XIII DEFICIENCY (PRO-RBD STUDY)”. You can find the abstract text at